There are several approaches taken to
accomplish the methods discussed above.
1) The "new" gene
can be incorporated into a retrovirus that has its virulence factors
altered so there is little negative effect on the patient. This
method would have a high immune response against the virus which
diminishes the effectiveness of the procedure.
2) The "new" gene
can be incorporated into cells harvested from the patient's body.
The new gene becomes part of the cells through homologous recombination.
This method presents no immune response but is more invasive.
3) The "new" gene
can be encapsulated in a lipid shell and delivered across the plasma
membrane in that manner. This is called a liposome.
4) There has also
been recent research into developing a 47th chromosome that could be
transferred into affected cells. This chromosome would work
alongside the existing 46 chromosomes and wouldn't affect their
functioning. It also has the ability to hold large amounts of DNA
for multigenic diseases.
Each method has its positives and its negatives. Certain methods are
better suited to certain cell types and gene sizes. Since this is a
relatively recent advance there hasn't been a single method stand out from
the others as far as effectiveness and safety are concerned. |